4 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | July 26, 2013 6:00 pm

4 Pharmaceutical Stocks to Buy Now

Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader[1] database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

Johnson & Johnson (NYSE:JNJ[2]) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. In Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Momentum, and Equity, JNJ also gets A’s. The stock price has risen 6.2% over the past month, better than the 1.7% decrease the S&P 500 has seen over the same period of time. The stock has a dividend yield of 2.6%. For more information, get Portfolio Grader’s complete analysis of JNJ stock[3].

Bristol-Myers Squibb (NYSE:BMY[4]) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock[5].

Watson Pharmaceuticals (NYSE:WPI[6]) boosts its rating from a B to an A this week. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[7].

Repros Therapeutics (NASDAQ:RPRX[8]) improves from a B to an A rating this week. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. Despite the upgrade, the stock’s price has not seen any measurable improvement over the past week. For more information, get Portfolio Grader’s complete analysis of RPRX stock[9].

Louis Navellier’s proprietary Portfolio Grader[10] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[11].

Endnotes:
  1. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  2. JNJ: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  3. For more information, get Portfolio Grader’s complete analysis of JNJ stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  4. BMY: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  5. For more information, get Portfolio Grader’s complete analysis of BMY stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  6. WPI: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  7. For more information, get Portfolio Grader’s complete analysis of WPI stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  8. RPRX: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  9. For more information, get Portfolio Grader’s complete analysis of RPRX stock: http://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  10. Portfolio Grader: http://navelliergrowth.investorplace.com/portfolio-grader/
  11. here: http://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: http://investorplace.com/2013/07/4-pharmaceutical-stocks-to-buy-now-jnj-bmy-wpi-15/
Short URL: http://invstplc.com/1fuUAod